On January 30, 2026, Yiteng Medical made an announcement stating that it had successfully closed a Series A funding round, raising nearly 100 million yuan. This round was spearheaded by HighLight Capital, and saw additional investments from Kunshan Guochuang Group and Kunyu Talent Fund. Capstone Partners played the role of financial advisor in this transaction. The majority of the raised funds will be earmarked for the research and development (R&D) refinement as well as the registration progress of high-end CT tubes, positioning the company to take the lead in China's CT tube industry.
